Anton Gueth, Director at ANTARES PHARMA, INC. (ATRS), bought 5,000 shares at $2.00 ($10K) on 2014-08-11, disclosed to the SEC on 2014-08-13.
Open-market purchase of $10k ATRS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2013-09-05 | $111K | — | Filing → |
| ATRS | SELL | 2013-08-05 | $110K | — | Filing → |
| ATRS | SELL | 2013-07-03 | $104K | — | Filing → |